Abstract:The aggregation of amyloid-beta protein (A beta) into fibrillary deposits is implicated in Alzheimer's disease (AD), and inhibiting A beta aggregation and clearing A beta fibrils are considered as promising strategies to treat AD. It has been reported that resveratrol (RSV) and epigallocatechin-3-gallate (EGCG), two of the most extensively studied natural polyphenols, are able to inhibit A beta fibrillization and remodel the preformed fibrillary aggregates into amorphous, non-toxic species. However, the mechanisms by which RSV inhibits A beta(42) aggregation and disrupts A beta(42) protofibril, as well as the inhibitory/disruptive mechanistic similarities and differences between RSV and EGCG, remain mostly elusive. Herein, we performed extensive all-atom molecular dynamics (MD) simulations on A beta(42) dimers (the early aggregation state of A beta(42)) and protofibrils (the intermediate of A beta(42) fibril formation and elongation) in the absence/presence of RSV or EGCG molecules. Our simulations show that both RSV and EGCG can bind with A beta(42) monomers and inhibit the dimerization of A beta(42). The binding of RSV with A beta(42) peptide is mostly via pi-pi stacking interactions, while the binding of EGCG with A beta(42) is mainly through hydrophobic, pi-pi stacking, and hydrogen-bonding interactions. Moreover, both RSV and EGCG disrupt the beta-sheet structure and K28-A42 salt bridges, leading to a disruption of A beta(42) protofibril structure. RSV mainly binds with residues whose side-chains point inwards from the surface of the protofibril, while EGCG mostly binds with residues whose side-chains point outwards from the surface of the protofibril. Furthermore, RSV interacts with A beta(42) protofibrils mostly via pi-pi stacking interactions, while EGCG interacts with A beta(42) protofibrils mainly via hydrogen-bonding and hydrophobic interactions. For comparison, we also explore the effects of RSV/EGCG molecules on the aggregation inhibition and protofibril disruption of the Iowa mutant (D23N) A beta. Our findings may pave the way for the design of more effective drug candidates as well as the utilization of cocktail therapy using RSV and EGCG for the treatment of AD.

Ginnalin A Inhibits Aggregation, Reverses Fibrillogenesis, and Alleviates Cytotoxicity of Amyloid (1-42)

Gallic Acid Disruption of Aβ1–42 Aggregation Rescues Cognitive Decline of APP/PS1 Double Transgenic Mouse

Design of Gallic Acid-Glutamine Conjugate and Chemical Implications for Its Potency Against Alzheimer's Amyloid- Fibrillogenesis

S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.

Macromolecular and small-molecule modulation of intracellular Aβ42 aggregation and associated toxicity.

Dimeric Bis (heptyl)‐cognitin Blocks Alzheimer's Β‐amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils

Retracted: S14G‐humanin Inhibits Aβ1–42 Fibril Formation, Disaggregates Preformed Fibrils, and Protects Against Aβ‐induced Cytotoxicity in Vitro

Glycosides and Their Corresponding Small Molecules Inhibit Aggregation and Alleviate Cytotoxicity of Aβ40

Protection Against Beta-Amyloid-Induced Synaptic And Memory Impairments Via Altering Beta-Amyloid Assembly By Bis(Heptyl)-Cognitin

Molecular mechanisms of resveratrol and EGCG in the inhibition of A<sub>42</sub> aggregation and disruption of A<sub>42</sub> protofibril: similarities and differences

Tabersonine Inhibits Amyloid Fibril Formation and Cytotoxicity of Aβ(1–42)

Real-time Analysis of the Biomolecular Interaction Between Gelsolin Andaβ1-42 Monomer and Its Implication for Alzheimer's Disease

P1-385: Protection against beta-amyloid-induced synaptic impairments via promotion of beta-amyloid oligomer aggregation by bis(heptyl)-cognitin

Hematoxylin Inhibits Amyloid Beta-Protein Fibrillation and Alleviates Amyloid-Induced Cytotoxicity

Genipin Attenuates Tau Phosphorylation and Aβ Levels in Cellular Models of Alzheimer’s Disease

Hydroxycinnamic Acid from Corncob and Its Structural Analogues Inhibit Aβ40 Fibrillation and Attenuate Aβ40-Induced Cytotoxicity.

Molecular Mechanism of Cyanidin-3-O-Glucoside Disassembling Aβ Fibril in Silico

The Study of a Bifunctional Aβ Aggregation Inhibitor with the Abilities of Anti-amyloid-β and Copper Chelation.

Molecular Hairpin: a Possible Model for Inhibition of Tau Aggregation by Tannic Acid.

IDENTIFICATION OF A SMALL MOLECULE INHIBITOR OF TAU AGGREGATION

Rational Design of Dual-Functionalized Gd@C82 Nanoparticles to Relieve Neuronal Cytotoxicity in Alzheimer's Disease Via Inhibition of Aβ Aggregation.